Related Experiment Video
Updated: Aug 10, 2026
04:34
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Zolpidem for persistent insomnia in SSRI-treated depressed patients
G M Asnis1, A Chakraburtty, E A DuBoff
1Department of Psychiatry, Montefiore Medical Center, Bronx, NY 10467, USA.
The Journal of Clinical Psychiatry
|November 5, 1999
Summary
Zolpidem (10 mg) effectively improved sleep and daytime function in depressed patients taking SSRIs. The medication was safe and well-tolerated, showing no signs of dependence or withdrawal.
Area of Science:
- Psychiatry
- Pharmacology
- Sleep Medicine
Background:
- Selective serotonin reuptake inhibitors (SSRIs) are common antidepressants.
- SSRIs can cause persistent insomnia in some patients.
- Adjunctive sleep therapy is often needed for SSRI-induced insomnia.
Purpose of the Study:
- To evaluate the efficacy and safety of zolpidem as adjunctive therapy for SSRI-treated patients with insomnia.
- To assess the impact of zolpidem on sleep quality, duration, and daytime functioning.
Main Methods:
- A randomized, double-blind, placebo-controlled study.
- 200 adult patients with major depressive disorder and persistent insomnia on stable SSRI treatment.
- Participants received either zolpidem (10 mg) or placebo nightly for 4 weeks.
Main Results:
- Zolpidem significantly improved sleep time, quality, and reduced awakenings compared to placebo.
- Patients on zolpidem reported feeling more refreshed and concentrated.
- No evidence of zolpidem dependence or withdrawal was observed.
Conclusions:
- Zolpidem (10 mg) is an effective and safe adjunctive treatment for insomnia in patients receiving SSRIs.
- Co-administration of zolpidem with SSRIs improved sleep and daytime functioning.
- The study supports zolpidem's role in managing SSRI-induced insomnia.
Related Concept Videos
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:23Sedatives and Hypnotics: Overview
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...